These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 37285616

  • 1. Combining robust urine biomarkers to assess chronic kidney disease progression.
    Bienaimé F, Muorah M, Metzger M, Broeuilh M, Houiller P, Flamant M, Haymann JP, Vonderscher J, Mizrahi J, Friedlander G, Stengel B, Terzi F, NephroTest Study Group.
    EBioMedicine; 2023 Jul; 93():104635. PubMed ID: 37285616
    [Abstract] [Full Text] [Related]

  • 2. Fasting Urinary Osmolality, CKD Progression, and Mortality: A Prospective Observational Study.
    Tabibzadeh N, Wagner S, Metzger M, Flamant M, Houillier P, Boffa JJ, Vrtovsnik F, Thervet E, Stengel B, Haymann JP, NephroTest Study Group.
    Am J Kidney Dis; 2019 May; 73(5):596-604. PubMed ID: 30777634
    [Abstract] [Full Text] [Related]

  • 3. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
    Smith ER, Lee D, Cai MM, Tomlinson LA, Ford ML, McMahon LP, Holt SG.
    Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
    [Abstract] [Full Text] [Related]

  • 4. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease.
    Liu KD, Yang W, Anderson AH, Feldman HI, Demirjian S, Hamano T, He J, Lash J, Lustigova E, Rosas SE, Simonson MS, Tao K, Hsu CY, Chronic Renal Insufficiency Cohort (CRIC) study investigators.
    Kidney Int; 2013 May; 83(5):909-14. PubMed ID: 23344473
    [Abstract] [Full Text] [Related]

  • 5. Urine Biomarkers of Kidney Tubule Health, Injury, and Inflammation are Associated with Progression of CKD in Children.
    Greenberg JH, Abraham AG, Xu Y, Schelling JR, Feldman HI, Sabbisetti VS, Ix JH, Jogalekar MP, Coca S, Waikar SS, Shlipak MG, Warady BA, Vasan RS, Kimmel PL, Bonventre JV, Denburg M, Parikh CR, Furth S, CKD Biomarkers Consortium, CKD Biomarker consortium.
    J Am Soc Nephrol; 2021 Oct; 32(10):2664-2677. PubMed ID: 34544821
    [Abstract] [Full Text] [Related]

  • 6. Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD.
    Malhotra R, Katz R, Jotwani V, Ambrosius WT, Raphael KL, Haley W, Rastogi A, Cheung AK, Freedman BI, Punzi H, Rocco MV, Ix JH, Shlipak MG.
    Clin J Am Soc Nephrol; 2020 Mar 06; 15(3):349-358. PubMed ID: 32111704
    [Abstract] [Full Text] [Related]

  • 7. Urinary cell-free mitochondrial and nuclear deoxyribonucleic acid correlates with the prognosis of chronic kidney diseases.
    Chang CC, Chiu PF, Wu CL, Kuo CL, Huang CS, Liu CS, Huang CH.
    BMC Nephrol; 2019 Oct 28; 20(1):391. PubMed ID: 31660901
    [Abstract] [Full Text] [Related]

  • 8. Relationships of Measured Iohexol GFR and Estimated GFR With CKD-Related Biomarkers in Children and Adolescents.
    Ng DK, Schwartz GJ, Warady BA, Furth SL, Muñoz A.
    Am J Kidney Dis; 2017 Sep 28; 70(3):397-405. PubMed ID: 28549535
    [Abstract] [Full Text] [Related]

  • 9. Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.
    Hsu CY, Xie D, Waikar SS, Bonventre JV, Zhang X, Sabbisetti V, Mifflin TE, Coresh J, Diamantidis CJ, He J, Lora CM, Miller ER, Nelson RG, Ojo AO, Rahman M, Schelling JR, Wilson FP, Kimmel PL, Feldman HI, Vasan RS, Liu KD, CRIC Study Investigators, CKD Biomarkers Consortium.
    Kidney Int; 2017 Jan 28; 91(1):196-203. PubMed ID: 28029431
    [Abstract] [Full Text] [Related]

  • 10. Serum and Urine Neutrophil Gelatinase-Associated Lipocalin Levels Measured at Admission Predict Progression to Chronic Kidney Disease in Sepsis-Associated Acute Kidney Injury Patients.
    Tuan PNH, Quyen DBQ, Van Khoa H, Loc ND, Van My P, Dung NH, Toan ND, Quyet D, Thang LV.
    Dis Markers; 2020 Jan 28; 2020():8883404. PubMed ID: 32908617
    [Abstract] [Full Text] [Related]

  • 11. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG, Uecer E, Stadler S, Birner C, Buchner S, Maier LS, Luchner A.
    Nephrology (Carlton); 2016 Jun 28; 21(6):490-8. PubMed ID: 26422793
    [Abstract] [Full Text] [Related]

  • 12. Biomarkers During Recovery From AKI and Prediction of Long-term Reductions in Estimated GFR.
    Wilson M, Packington R, Sewell H, Bartle R, McCole E, Kurth MJ, Richardson C, Shaw S, Akani A, Banks RE, Selby NM.
    Am J Kidney Dis; 2022 May 28; 79(5):646-656.e1. PubMed ID: 34653541
    [Abstract] [Full Text] [Related]

  • 13. Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.
    Lobato GR, Lobato MR, Thomé FS, Veronese FV.
    Braz J Med Biol Res; 2017 Mar 30; 50(5):e6106. PubMed ID: 28380198
    [Abstract] [Full Text] [Related]

  • 14. Urinary creatinine excretion, measured glomerular filtration rate and CKD outcomes.
    Tynkevich E, Flamant M, Haymann JP, Metzger M, Thervet E, Boffa JJ, Vrtovsnik F, Houillier P, Froissart M, Stengel B, NephroTest Study Group.
    Nephrol Dial Transplant; 2015 Aug 30; 30(8):1386-94. PubMed ID: 25817225
    [Abstract] [Full Text] [Related]

  • 15. Prognostic significance of NGAL in early stage chronic kidney disease.
    Basturk T, Sari O, Koc Y, Eren N, Isleem M, Kara E, Sevinc M, Sakaci T, Ahbap E, Hasbal NB, Bayrakdar Caglayan F, Unsal A.
    Minerva Urol Nefrol; 2017 Jun 30; 69(3):307-312. PubMed ID: 27768023
    [Abstract] [Full Text] [Related]

  • 16. Urinary ammonia and long-term outcomes in chronic kidney disease.
    Vallet M, Metzger M, Haymann JP, Flamant M, Gauci C, Thervet E, Boffa JJ, Vrtovsnik F, Froissart M, Stengel B, Houillier P, NephroTest Cohort Study group.
    Kidney Int; 2015 Jul 30; 88(1):137-45. PubMed ID: 25760321
    [Abstract] [Full Text] [Related]

  • 17. Urinary neutrophil gelatinase-associated lipocalin as a predictor of cardiovascular events in patients with chronic kidney disease.
    Hasegawa M, Ishii J, Kitagawa F, Takahashi K, Hayashi H, Koide S, Tomita M, Takahashi H, Ozaki Y, Yuzawa Y.
    Heart Vessels; 2015 Jan 30; 30(1):81-8. PubMed ID: 24378882
    [Abstract] [Full Text] [Related]

  • 18. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
    Xiang D, Zhang H, Bai J, Ma J, Li M, Gao J, Wang C.
    Int J Clin Exp Pathol; 2014 Jan 30; 7(10):7172-81. PubMed ID: 25400814
    [Abstract] [Full Text] [Related]

  • 19. Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
    Messchendorp AL, Meijer E, Visser FW, Engels GE, Kappert P, Losekoot M, Peters DJM, Gansevoort RT, on behalf of the DIPAK-1 study investigators.
    Am J Nephrol; 2019 Jan 30; 50(5):375-385. PubMed ID: 31600749
    [Abstract] [Full Text] [Related]

  • 20. Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women.
    Lim WH, Lewis JR, Wong G, Teo R, Lim EM, Byrnes E, Prince RL.
    Am J Nephrol; 2015 Jan 30; 41(2):156-64. PubMed ID: 25824561
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.